top of page
Copy of Your New Chapter; no bg (1000 x 500 px).png
(509) 934-0245

Does TMS Work? And is my insurance going to cover it?

  • Writer: Dr. Kiira Tietjen
    Dr. Kiira Tietjen
  • Jun 16
  • 5 min read

When people ask about TMS, two of the most common questions are:

Does it work?
Will my insurance cover it?

Those are both important questions — but they are not the same question.


A treatment can be supported by research before insurance covers it. A treatment can be FDA-cleared before insurance companies update their policies. And sometimes, a treatment can be covered by insurance only if the patient meets very specific rules.


That is why it helps to separate three different categories:

Evidence-based
FDA-cleared or FDA-approved
Covered by insurance

These categories overlap, but they are not the same.


Evidence-based versus FDA-cleared versus covered by insurance

1. Evidence-Based: Does Research Support It?

Evidence-based means there is research or clinical data showing that a treatment can help.

For TMS, the evidence is strongest for major depressive disorder, especially when depression has not improved enough with medication. TMS has also been studied for other conditions and treatment approaches, including OCD, adolescent depression, and accelerated treatment schedules.


Evidence is the broadest category. It asks: Does the science support this treatment?


That is different from asking whether the FDA has reviewed it or whether insurance will pay for it.

This is not unique to TMS. In psychiatry, many medications are used in evidence-based ways that are technically "off label". Off label means the medication is being used for a condition that is not specifically listed in the FDA approval.


For example, a medication may have evidence for pediatric depression, insomnia, adult ADHD, or depression augmentation, even if the FDA approval is actually for a different condition. That does not mean the treatment is inappropriate. It means the evidence and the FDA label are not always identical.


Psychiatric medications: what the evidence says versus what is FDA-approved

2. FDA-Cleared or FDA-Approved: Has the FDA Reviewed It for This Use?

For medications, people usually say FDA-approved.


For medical devices like TMS systems, the more accurate term is usually FDA-cleared.

FDA clearance means the device has gone through a formal FDA process for a specific use. It is an important safety and regulatory milestone.


For TMS, FDA-cleared uses include adult depression, adolescent depression for certain systems, OCD for certain systems and protocols, and newer accelerated treatment protocols for certain devices.


But FDA clearance does not mean every insurance company will cover it. FDA clearance answers: Has the FDA reviewed this device or treatment for this use?


It does not answer: Will my insurance pay for it?

3. Covered by Insurance: Will a Payer Pay for It?

Insurance coverage is a payment decision.


One of the most frustrating parts of modern medicine is that insurance companies do not simply ask, “Does this treatment work?” They often create their own rules about who qualifies, what must be tried first, and what documentation is required. In other words, coverage is not determined only by the evidence or the FDA. It is also determined by payer policy.


This is why a treatment can be evidence-based and FDA-cleared, but still not covered by a specific insurance plan. It is also why coverage can vary from one plan to another.


For TMS, insurance coverage is most consistent for adult depression when the patient meets the insurance plan’s criteria. Those criteria often include documentation of prior medication trials, diagnosis, symptom severity, and other treatment history.


Coverage is more variable for adolescent depression, OCD, and newer accelerated TMS protocols. Some plans cover them. Some do not. Some may require extra documentation. Some may not have updated their policies yet.


Insurance-covered does not mean “scientifically proven,” and not covered does not mean “not legitimate.” It often means the insurer has chosen its own criteria for payment.

Medical Examples: This Happens Outside TMS Too

This issue is not unique to mental health care.

For example, Botox for chronic migraine is evidence-based and FDA-approved. Insurance may cover it, but each plan sets its own approval rules. A patient may need to document headache frequency, prior medication trials, and other details before coverage is approved.

GLP-1 medications for obesity are evidence-based and FDA-approved for certain patients, but insurance coverage is often limited, restricted, or excluded.

Propranolol for performance anxiety is commonly used in an evidence-supported way, but that use is off label. The medication is FDA-approved for other conditions, not specifically for performance anxiety.


Medical examples of authorization options

So the pattern is common across medicine:

Research, FDA status, and insurance coverage do not always line up perfectly.

How This Applies to TMS

TMS is not one single category. Different TMS uses fall into different places.

  • Adult depression has the strongest overlap:evidence-based, FDA-cleared, and often covered by insurance when criteria are met.

  • Teen depression is evidence-supported and FDA-cleared for certain systems, but insurance coverage may vary by plan.

  • OCD is FDA-cleared for certain systems and protocols, but coverage is less consistent than adult depression.

  • SAINT protocol is a specific accelerated protocol with FDA clearance through Magnus. It has important research behind it, but a smaller evidence pool than standard depression TMS and has generally not been broadly covered by insurance.

  • Accelerated TMS broad protocols received expanded FDA clearance through MagVenture in 2026. This is an important step forward, but most insurance policies have not yet caught up.


That is why the answer to “Does TMS work?” may be yes, while the answer to “Will insurance cover it?” may still depend on the protocol, diagnosis, device, age, payer, and plan rules.


TMS evidence vs clearance vs coverage

One More Question: Is It Right for You?

There is one more layer: what is right for you.

A treatment can be evidence-based, FDA-cleared, and covered by insurance, but that does not automatically mean it is the right fit for every person. That is the clinical decision a medical provider makes with you.

For TMS, that includes asking whether the treatment matches your diagnosis and symptoms, whether the protocol is appropriate, and whether there are any major safety concerns or strict contraindications — such as certain implanted devices, seizure risk factors, or other medical issues that need careful review.


The first three questions are about the treatment:

Does research support it? Has the FDA cleared it? Will insurance cover it?


The fourth question is about the person:

Is this treatment appropriate and safe for me?


Bottom Line

When considering TMS, it helps to ask four separate questions:

1. Is it evidence-based?Does research support this treatment?

2. Is it FDA-cleared?Has the FDA reviewed this device or protocol for this use?

3. Is it covered by insurance?Will this specific insurance plan pay for it under its rules?

4. Is it clinically appropriate for me?Is it safe and a good fit based on my symptoms, history, and medical factors?


At New Chapter TMS, we help patients understand each of these pieces clearly. Our goal is to make the process less confusing, so you can make an informed decision about your care.

If you ever feel unsafe or hopeless, please reach out right now: call or text 988 (Suicide & Crisis Lifeline). You are not alone.

Comments

bottom of page